HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

TMC 256C1

inhibits IL-4 signal transduction; structure in first source

Also Known As:

TMC-256C1

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        TMC 256C1: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        TMC 256C1: 1

Experts

1.	Cho, Kwang-Ho: 1 article (04/2016)
2.	Kim, Dong-Cheol: 1 article (04/2016)
3.	Kim, Youn-Chul: 1 article (04/2016)
4.	Ko, Wonmin: 1 article (04/2016)
5.	Oh, Hyuncheol: 1 article (04/2016)
6.	Sohn, Jae Hak: 1 article (04/2016)
7.	Yim, Joung Han: 1 article (04/2016)
8.	Yoon, Chi-Su: 1 article (04/2016)

Related Diseases

1.	Inflammation (Inflammations) 04/08/2016 - "TMC-256C1 was shown to develop a cellular resistance to oxidative damage caused by glutamate-induced cytotoxicity and reactive oxygen species (ROS) generation in HT22 cells, and suppress the inflammation process in LPS-stimulated BV2 cells. "

Related Drugs and Biologics

1.	Glutamic Acid (Glutamate)
2.	Reactive Oxygen Species (Oxygen Radicals)